CAS 2016/A/4676, Arijan Ademi v. UEFA, 24 March 2017. In the Ademi award, the main issue in front of the CAS panel was whether the violation was 'not intentional', a question the panel had to resolve in absence of conclusive evidence as to how the substance entered the Athlete’s body. The award in essence asks: [...]
In Fall 2015, WADA announced its decision to add the anti-ischemic drug “Meldonium” to its Prohibited List with effect on 1 January 2016, after the Monitoring Program and observation period 2015 revealed “evidence of its use by athletes with the intention of enhancing performance” (Explanatory Notice to the 2016 List). Few observers could have predicted [...]
Download the Bekele Blog Post HERE CAS Award: Alemitu Bekele Degfa v. Turkish Athletics Federation & IAAF, CAS 2013/A/3080, March 14, 2014. In this award, recently published in the CAS bulletin, Alemitu Bekele Degfa – a long-distance runner of Turkish Nationality and Ethiopian origin – was found to have committed an anti-doping violation with aggravating circumstances. [...]
